We are live on ! Find out more
AIP

Ameritas Investment Partners Portfolio holdings

AUM $3.25B
1-Year Est. Return 28.52%
This Fund
S&P 500
This Quarter Est. Return
+0.02%
1 Year Est. Return
+28.52%
3 Year Est. Return
+86.82%
5 Year Est. Return
+110.6%
10 Year Est. Return
+500.3%
AUM
$2.08B
AUM Growth
-$109M
Cap. Flow
-$88M
Cap. Flow %
-4.22%
Top 10 Hldgs %
17.5%
Holding
3,019
New
52
Increased
262
Reduced
623
Closed
69

Top Buys

Rank Stock Value
1
V icon
Visa
V
+$2.94M
2
VZ icon
Verizon
VZ
+$2.82M
3
EHC icon
Encompass Health
EHC
+$2.04M
4
WBS icon
Webster Financial
WBS
+$1.98M
5
ABBV icon
AbbVie
ABBV
+$1.93M

Sector Composition

Rank Sector Weight
1 Technology 13.98%
2 Financials 13.14%
3 Industrials 10.38%
4 Healthcare 8.96%
5 Consumer Discretionary 8.57%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
OMNT
2876
DELISTED
Ominto, Inc. Common Stock
OMNT
$4K ﹤0.01%
1,246
RVLT
2877
DELISTED
Revolution Lighting Technologies, Inc. - Class A
RVLT
$4K ﹤0.01%
1,081
ASCMA
2878
DELISTED
Ascent Capital Group, Inc. Series A
ASCMA
$4K ﹤0.01%
1,027
ACWI icon
2879
iShares MSCI ACWI ETF
ACWI
$33.3B
$3K ﹤0.01%
55
+15
+38% +$1.1K
CRVS icon
2880
Corvus Pharmaceuticals
CRVS
$1.24B
$3K ﹤0.01%
259
DES icon
2881
WisdomTree US SmallCap Dividend Fund
DES
$2.21B
$3K ﹤0.01%
131
DLN icon
2882
WisdomTree US LargeCap Dividend Fund
DLN
$6.4B
$3K ﹤0.01%
78
FBT icon
2883
First Trust NYSE Arca Biotechnology Index Fund
FBT
$2.81B
$3K ﹤0.01%
25
-40
-62% -$5.46K
FLNT
2884
Fluent
FLNT
$130M
$3K ﹤0.01%
197
HBB icon
2885
Hamilton Beach Brands
HBB
$445M
$3K ﹤0.01%
149
IBB icon
2886
iShares Biotechnology ETF
IBB
$9.81B
$3K ﹤0.01%
30
-259
-90% -$28.7K
METC icon
2887
Ramaco Resources Class A
METC
$647M
$3K ﹤0.01%
444
OVID icon
2888
Ovid Therapeutics
OVID
$482M
$3K ﹤0.01%
443
RFL icon
2889
Rafael Holdings
RFL
$99.8M
$3K ﹤0.01%
+665
New +$3.15K
SMLV icon
2890
State Street SPDR US Small Cap Low Volatility Index ETF
SMLV
$259M
$3K ﹤0.01%
+40
New +$3.6K
VERI icon
2891
Veritone
VERI
$139M
$3K ﹤0.01%
222
VEU icon
2892
Vanguard FTSE All-World ex-US ETF
VEU
$70B
$3K ﹤0.01%
60
-10
-14% -$557
RNTX
2893
Rein Therapeutics
RNTX
$69.9M
$3K ﹤0.01%
22
SALM
2894
DELISTED
Salem Media Group, Inc. Class A Common Stock
SALM
$3K ﹤0.01%
861
OFED
2895
DELISTED
Oconee Federal Financial Corp.
OFED
$3K ﹤0.01%
109
SIOX
2896
DELISTED
Sio Gene Therapies Inc. Common Stock
SIOX
$3K ﹤0.01%
328
MDLY
2897
DELISTED
Medley Management Inc
MDLY
$3K ﹤0.01%
52
GNCA
2898
DELISTED
Genocea Biosciences, Inc.
GNCA
$3K ﹤0.01%
314
IMDZ
2899
DELISTED
Immune Design Corp.
IMDZ
$3K ﹤0.01%
874
AQMS icon
2900
Aqua Metals
AQMS
$9.38M
$2K ﹤0.01%
4

Similar funds

Ameritas Investment Partners's Q1 2018 Portfolio in Review

As of Q1 2018, Ameritas Investment Partners held 3,019 positions worth $2.08B, down 5% from $2.19B the previous quarter. Its ten largest holdings account for 18% of the portfolio.

Ameritas Investment Partners withdrew a net $88M in Q1 2018, closing 69 positions and reducing 623 holdings. Its most notable exit was Bioverativ Inc. Common Stock, an estimated $1.75M position sold in full.

By sector, the portfolio is most concentrated in Technology at 14% of assets, up from 13% a quarter earlier, followed by Financials and Industrials.

Against the trend, Ameritas Investment Partners opened a new position in Encompass Health worth $2.16M.

  • Ameritas Investment Partners's largest Q1 2018 buy was Encompass Health: 47,494 shares worth $2.16M.
  • Ameritas Investment Partners added most to Visa in Q1 2018, an estimated $2.94M increase.
  • Ameritas Investment Partners's biggest Q1 2018 reduction was Alerian MLP ETF, cutting an estimated $16.3M.
  • Ameritas Investment Partners fully exited Bioverativ Inc. Common Stock in Q1 2018, selling an estimated $1.75M.
  • Ameritas Investment Partners's ten largest holdings make up 18% of its $2.08B portfolio in Q1 2018.
  • Ameritas Investment Partners opened 52 new positions and closed 69 in Q1 2018.
  • Ameritas Investment Partners's portfolio value fell 5% quarter-over-quarter to $2.08B.

Based on Ameritas Investment Partners's 13F filing for Q1 2018, filed 15 May 2018.